National Traditional Chinese Medicine Supervision Blue Book: 2021 Chinese medicine revenue reached 691.9 billion yuan in annual revenue

According to the Blue Book of Traditional Chinese Medicine Supervision, which was directed by the State Drug Administration, it was shown that as of the end of 2021, there were 2,225 Chinese medicine production enterprises in my country. In 2021, my country's traditional Chinese medicine industry grew steadily. The annual operating income reached 691.9 billion yuan, an increase of 12.4%year -on -year.

Zhao Junning, deputy director of the State Drug Administration, said that in 2021, the State Drug Administration used special rectification, special inspection and inspection methods to further regulate the production order of Chinese medicine drinking tablets. %.

The blue book of traditional Chinese medicine supervision shows that in 2021, traditional Chinese medicine random inspection focuses on the concerns of the masses, the quality monitoring of the quality of traditional Chinese medicine, the timely reflecting the safety of drugs, and controlling hidden risks. my country has established a traditional Chinese medicine quality and safety supervision system that meets the development and supervision needs of the Chinese medicine industry, covering all aspects of the entire life cycle of Chinese medicine, covering the entire Chinese medicine registration review approval, inspection inspection, sampling inspection, production circulation, adverse reaction monitoring, and protection of traditional Chinese medicine varieties. The chain has better guarantee the safety and effectiveness of the clinical medication of Chinese medicine.

Responsible editor: Wang Shidan | Audit: Li Zhen | Director: Wan Junwei

- END -